Baseline characteristics of phase 3 randomized controlled trials of omalizumab in chronic rhinosinusitis with nasal polyps Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Bachert, C.; Gevaert, P.; Corren, J.; Mullol, J.; Han, J.; Ow, R.; Hussain, I; Islam, L.; Fogel, R.; Kaufman, D.; Omachi, T.

publication date

  • August 1, 2019


published in


start page

  • 329

end page

  • 330


  • 74